For years, the clinical trial industry has been sold an appealing idea: participant adherence is largely a problem that can ...
In this conversation between Rebecca Johnson, PhD, ACT EAB member and clinical research recruitment and inclusion executive ...
In today's ACT Brief, we examine leadership instability and regulatory uncertainty during Makary's FDA tenure, how lived ...
Signant’s acquisition of Ametris consolidates patient-reported outcomes and continuous wearable sensing into one workflow, reducing multi-vendor operational overhead and dataset reconciliation ...
FDA Commissioner Marty Makary, MD, MPH, resigned Tuesday, according to The Associated Press, just 13 months after being ...
In today's ACT Brief, we examine cost models for imaging infrastructure in clinical trials, how community relationships ...
On-premise imaging stacks concentrate costs in validation, site-level maintenance, and monitoring, yielding ~$3.2M TCO (~$53.5k/patient) even when IT/QA staffing is amortized across trials. Cloud DIY ...
In today's ACT Brief, we examine how protocol design decisions have become strategic business choices with outsized consequences for smaller companies, what clinical research sites need to compete and ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results